Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Catapres Tablets 100mcg - PA2256/003/001
- Instanyl 50mcg Nasal Spray - EU/1/09/531/010-013
- Rifater 50mg/300mg/120mg Tablets - PA0540/067/001
- RoActemra 162mg Solution for Injection in Pre Filled Syringe - EU/1/08/492/007
- Stesolid Rectal Solution 10mg - PA2315/137/002
- Teicoplanin 200 mg Powder and Solvent for Solution for Injection/Infusion or Oral Solution - PA1122/009/001
- Xylocaine 2% with Adrenaline (Epinephrine) (1:200,000) Solution for Injection - PA1691/027/001
- Zyvox 2 mg/ml solution for infusion - PA0822/143/002
The following shortages have been resolved and supply has resumed to the Irish market:
- Aldactone 50mg Film Coated Tablets – PA0822/110/002
- Aprovel 300mg Film Coated Tablets - EU/1/97/046/007
- Ciprager 20 mg Film Coated Tablets - PA0577/047/002
- Quentiax SR 200mg Prolonged Release Tablets - PA1347/045/002
- VFEND 200mg Powder for Solution for Infusion - EU/1/02/212/025
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.